After the fall: improving osteoporosis treatment following hip fracture.

Abstract

Osteoporotic hip fractures can be life changing and can increase mortality. Treatment of osteoporosis following hip fracture is often delayed. We began offering osteoporosis medication during hospitalization for hip fracture, dramatically increasing the number of patients meeting standard of care.

INTRODUCTION:

Osteoporotic hip fracture is a debilitating condition with major morbidity and mortality implications. Osteoporosis medication given within 90 days of hip fracture improves mortality and reduces risk of future fractures. The aim of this project was to improve rates of timely osteoporosis treatment following fragility hip fracture.

METHODS:

This was a two-step intervention utilizing the Plan-Do-Study-Act cycle, beginning with resident-focused education in cycle 1. In cycle 2, we offered osteoporosis medication to inpatients for hip fracture with help from a new electronic order set.

RESULTS:

Prior to this intervention, 32% of patients received osteoporosis medication within 90 days of fragility hip fracture; this improved to 81% after intervention.

CONCLUSIONS:

Resident education and an electronic order set dramatically improved the percentage of patients meeting standard of care with osteoporosis pharmacotherapy following fragility fracture.

• Authors: B W Kuiper, S Graybill, J M Tate, N Kaufman, D Bersabe
• Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (Osteoporos Int) Vol. 29 Issue 6 Pg. 1295-1301 (Jun 2018) ISSN: 1433-2965 [Electronic] England
• PMID: 29464276 (Publication Type: Journal Article)

Chemical References

• Bone Density Conservation Agents
• Denosumab
• Zoledronic Acid

Topics

• Accidental Falls
• Aged
• Bone Density Conservation Agents (administration & dosage, therapeutic use)
• Denosumab (administration & dosage, therapeutic use)
• Drug Administration Schedule
• Hip Fractures (etiology, prevention & control)
• Hospitalization
• Humans
• Osteoporosis (complications, drug therapy)
• Osteoporotic Fractures (prevention & control)
• Quality Improvement (organization & administration)
• Retrospective Studies
• Secondary Prevention (standards)
• Standard of Care
• Texas
• Zoledronic Acid (administration & dosage, therapeutic use)